Ranking · Burden

Age-standardized mortality rate

Deaths per 100,000 person-years, age-standardized to the standard population declared by the source.

Computedci-asmr-v1unit: per 100,000higher = worseAll metrics

Rank	Δ	Cancer	Age-standardized mortality rate (per 100,000)	Percentile	Confidence	Sources	Why #n?
1	=	Malignant Lung Neoplasm	27.9	100	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 4026 siteDefinition USCS "Lung and Bronchus" (ICD-10 C34; ICD-O-3 C340-C349) ranking row 2608844
2	=	Malignant Pancreatic Neoplasm	11.3	95.5	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 6066 siteDefinition USCS "Pancreas" (ICD-10 C25; ICD-O-3 C250-C259) ranking row 2608845
3	=	Malignant Breast Neoplasm	10.2	90.9	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 8820 siteDefinition USCS "Male and Female Breast" (ICD-10 C50; ICD-O-3 C500-C509) ranking row 2608846
4	=	Malignant Colon Neoplasm	9.5	86.4	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 1122 siteDefinition USCS "Colon excluding Rectum" (ICD-10 C18, C26.0; ICD-O-3 C180-C189, C260) ranking row 2608847
5	▲1	Malignant Liver Neoplasm	6.6	81.8	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 3720 siteDefinition USCS "Liver and Intrahepatic Bile Duct" (ICD-10 C22; ICD-O-3 C220-C221) ranking row 2608848
6	▲1	Leukemia	5.5	77.3	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 3414 siteDefinition USCS "Leukemias" (ICD-10 C91-C95 (leukemia recodes; C90.1 plasma cell leukemia included by SEER); ICD-O-3 leukemia histologies 9733-9948 per SEER site recode) ranking row 2608849
7	▲1	Non-Hodgkin Lymphoma	4.5	72.7	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 5556 siteDefinition USCS "Non-Hodgkin Lymphoma" (ICD-10 C82-C85, C96.3; ICD-O-3 histology 9590-9597, 9670-9729, 9735, 9737-9738 (+9811-9818, 9823, 9827, 9837 outside marrow/blood)) ranking row 2608850
8	▲1	Malignant Central Nervous System Neoplasm	4.3	68.2	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 612 siteDefinition USCS "Brain and Other Nervous System" (ICD-10 C70, C71, C72; ICD-O-3 C700-C709, C710-C719, C720-C729) ranking row 2608851
9	▲1	Malignant Bladder Neoplasm	3.9	63.6	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 7596 siteDefinition USCS "Urinary Bladder" (ICD-10 C67; ICD-O-3 C670-C679) ranking row 2608852
10	▲1	Malignant Esophageal Neoplasm	3.6	59.1	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 1632 siteDefinition USCS "Esophagus" (ICD-10 C15; ICD-O-3 C150-C159) ranking row 2608853
11	▲1	Malignant Kidney Neoplasm	3.4	54.5	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 2802 siteDefinition USCS "Kidney and Renal Pelvis" (ICD-10 C64-C65; ICD-O-3 C649, C659) ranking row 2608854
12	▲1	Malignant Rectal Neoplasm	3.1	50	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 6372 siteDefinition USCS "Rectum and Rectosigmoid Junction" (ICD-10 C19-C20; ICD-O-3 C199, C209) ranking row 2608855
13	▲3	Malignant Gastric Neoplasm	2.6	45.5	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 6984 siteDefinition USCS "Stomach" (ICD-10 C16; ICD-O-3 C160-C169) ranking row 2608856
13	▲2	Multiple Myeloma	2.6	45.5	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 4944 siteDefinition USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) ranking row 2608857
15	▲2	Cutaneous Melanoma	2	36.4	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 4332 siteDefinition USCS "Melanomas of the Skin" (ICD-10 C43; ICD-O-3 C440-C449 with histology 8720-8790) ranking row 2608858
16	▲7	Malignant Laryngeal Neoplasm	0.9	31.8	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 3108 siteDefinition USCS "Larynx" (ICD-10 C32; ICD-O-3 C320-C329) ranking row 2608859
17	▲8	Malignant Mesothelioma	0.5	27.3	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 4638 siteDefinition USCS "Mesothelioma" (ICD-10 C45; ICD-O-3 histology 9050-9055 (any site)) ranking row 2608860
17	▲8	Malignant Thyroid Gland Neoplasm	0.5	27.3	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 7290 siteDefinition USCS "Thyroid" (ICD-10 C73; ICD-O-3 C739) ranking row 2608861
19	▲8	Malignant Anal Neoplasm	0.4	18.2	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 306 siteDefinition USCS "Anus, Anal Canal and Anorectum" (ICD-10 C21; ICD-O-3 C210-C212, C218) ranking row 2608862
20	▲9	Malignant Salivary Gland Neoplasm	0.3	13.6	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 6678 siteDefinition USCS "Salivary Gland" (ICD-10 C07-C08; ICD-O-3 C079-C089) ranking row 2608863
21	▲9	Hodgkin Lymphoma	0.2	9.1	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 2040 siteDefinition USCS "Hodgkin Lymphoma" (ICD-10 C81; ICD-O-3 histology 9650-9667 (nodal and extranodal)) ranking row 2608864
21	▲9	Malignant Nasopharyngeal Neoplasm	0.2	9.1	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 5250 siteDefinition USCS "Nasopharynx" (ICD-10 C11; ICD-O-3 C110-C119) ranking row 2608865
23	▲9	Malignant Hypopharyngeal Neoplasm	0.1	0	High confidence	cdc-uscs	inputs sourceId CI-SOURCE-00000012 estimateType observed observationId 2346 siteDefinition USCS "Hypopharynx" (ICD-10 C12-C13; ICD-O-3 C129, C130-C139) ranking row 2608866

Data updated 16 hours agoSource updated unknown23 eligible entities · inputs hash 075bdb903aa37f48ae5b75b4

Methodology

How this table was built

Formula: epidemiology_observations.value WHERE metric = as_mortality_rate (standard_population fixed per scope)
Version: ci-asmr-v1
Scope: USA · both sexes · all ages · 2024 · top-level cancers
Scope key: geo=USA|sex=all|age=all|year=2024|level=top
Eligible entities: 23
Generated: Sep 29, 2026, 06:30 AM UTC
Inputs hash: 075bdb903aa37f48ae5b75b4
Sources: U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Aggregation: none

Eligibility

requires: as_mortality_rate
entityLevel: top

Full methodology · ties share a rank (1, 2, 2, 4) · previous rank refers to the last snapshot of the same scope.

Download CSV (with attribution)

Burden and lethality metrics depend on registry definitions (site groups, standard population, estimate type). Compare only within one table.

Deadliness annual deaths ≠ age-standardized mortality ≠ mortality-to-incidence ratio ≠ 5-year survival. Each answers a different question.